Does any one have more up to date figures on branded and generic lovenox (enoxaparin) by indication?
I’ve been told that, to get IMS script data by indication, customers must subscribe to a more expensive service than the one that furnishes new and total weekly scripts. So the short answer to your question would appear to be no.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”